Search
Now showing items 11-20 of 36
Article
The major circulating immunosuppressive activity in American visceral leishmaniasis patients is associated with a high-molecular weight fraction and is not mediated by IgG, IgG immune complexes or lipoproteins
| Date Issued:
2006 | Copyright:
open access
Article
Serum soluble markers in the evaluation of treatment in human visceral leishmaniasis
| Date Issued:
1995 | Copyright:
open access
Article
Transforming growth factor-beta in human cutaneous leishmaniasis
| Date Issued:
1995 | Copyright:
open access
Article
Adult T-cell leukemia/lymphoma triggered by adalimumab.
| Date Issued:
2013 | Copyright:
open access
Article
High HTLV-1 proviral load, a marker for HTLV-1 associated myelopathy/tropical spastic paraparesis, is also detected in patients with infective dermatitis associated with HTLV-1
| Date Issued:
2009 | Copyright:
open access
Article
Biological behavior of Leishmania amazonensis isolated from humans with cutaneous, mucosal, or visceral leishmaniasis in BALB/C mice
| Date Issued:
1996 | Copyright:
open access
Article
Flower cellsin patient swith infective dermatitis associated with HTLV-1
| Date Issued:
2010 | Copyright:
open access
Article
Randomized, double-blind study of stibogluconate plus human granulocyte macrophage colony-stimulating factor versus stibogluconate alone in the treatment of cutaneous Leishmaniasis
| Date Issued:
1999 | Copyright:
open access
Article
IL-1β Production by Intermediate Monocytes Is Associated with Immunopathology in Cutaneous Leishmaniasis
| Date Issued:
2018 | Copyright:
open access